How could anyone vote that ACHN and INHX were winners? Their drugs didn't surprise anyone or substantially change their valuation. It seems ridiculous to vote for anyone besides VRUS( or a distant 2nd BMY).
Analysts are turning into not-so cheap prostitutes. Even Schoenebaum is a bit obnoxious with his constant harping about HGSI. IMO, he gets too much attention in the media and his buddy, AF.